SHH:688617
APT Medical Inc. · SHH · Healthcare · CNY · FY for 2024
Figures on this page computed 2026-11-08 12:40 UTC
Last close
n/aCNY
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
59.4xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
- Computed from the filing for 2024
46.0%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
32.6%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
4.5%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
0.004Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
Price is the furthest below its sector's middle: 0.08 against 0.36 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2024
- Sales2.35x
Its own average over 8 years, 879.9M.
- Profit2.66x
Its own average over 8 years, 252.8M.
- Free cash flow0.84x
Its own average over 8 years, 110.5M.
- Debt0.23x
Its own average over 8 years, 48.6M.
- Pricen/a
Its own average over 0 years. Market data
Profit is furthest from its own average, at 2.66 times.
The filed years, as a table
8Each line is 100 at 2017-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2017-12-31 | 100.0 | 100.0 | 100.0 |
| 2018-12-31 | 157.8 | 62.4 | 100.0 |
| 2019-12-31 | 263.7 | 239.5 | 100.1 |
| 2020-12-31 | 313.0 | 321.3 | 99.8 |
| 2021-12-31 | 541.0 | 603.0 | 131.2 |
| 2022-12-31 | 793.9 | 1,038.3 | 135.1 |
| 2023-12-31 | 1,077.3 | 1,548.4 | 134.9 |
| 2024-12-31 | 1,348.7 | 1,952.1 | 134.2 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2024
- Reported in
- CNY
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2024
- Reported in
- CNY
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2024
- Reported in
- CNY
Figures behind the shape
Growth
38.6%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate38.6%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
Five-year EPS growth rate43.8%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
One-year change in net income26.1%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
Returns on capital
46.0%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital46.0%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
Return on equity26.8%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
Return on assets22.6%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
Margins
71.9%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin71.9%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
Operating margin36.5%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
Net margin32.6%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
Free cash flow margin4.5%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
Price
59.4xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings59.4x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
- Computed from the filing for 2024
Price to book16.0x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
- Computed from the filing for 2024
- computed
- Computed from the filing for 2024
EV to EBITDA46.7x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
Price to sales ratio19.5x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
- Computed from the filing for 2024
- Computed from the filing for 2024
Safety
0.004safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equity0.004
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
Current ratio3.98
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
Interest coverage320.2x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
Altman Z-Score59.47
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
What it pays out
19.9%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
Payout ratio19.9%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
Dividend cover ratio0.7x
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.